A detailed history of Doliver Advisors, LP transactions in Merck & Co., Inc. stock. As of the latest transaction made, Doliver Advisors, LP holds 13,087 shares of MRK stock, worth $1.3 Million. This represents 0.43% of its overall portfolio holdings.

Number of Shares
13,087
Previous 13,333 1.85%
Holding current value
$1.3 Million
Previous $1.65 Million 9.94%
% of portfolio
0.43%
Previous 0.47%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 02, 2024

SELL
$111.15 - $128.97 $27,342 - $31,726
-246 Reduced 1.85%
13,087 $1.49 Million
Q2 2024

Jul 12, 2024

SELL
$123.8 - $132.96 $12,256 - $13,163
-99 Reduced 0.74%
13,333 $1.65 Million
Q1 2024

Apr 12, 2024

SELL
$113.24 - $131.95 $49,032 - $57,134
-433 Reduced 3.12%
13,432 $1.77 Million
Q4 2023

Jan 03, 2024

SELL
$100.18 - $109.02 $2,003 - $2,180
-20 Reduced 0.14%
13,865 $1.51 Million
Q3 2023

Oct 10, 2023

BUY
$102.95 - $114.33 $14,824 - $16,463
144 Added 1.05%
13,885 $1.43 Million
Q2 2023

Aug 07, 2023

SELL
$108.61 - $118.38 $9,231 - $10,062
-85 Reduced 0.61%
13,741 $1.59 Million
Q1 2023

May 12, 2023

BUY
$102.94 - $114.86 $33,558 - $37,444
326 Added 2.41%
13,826 $1.47 Million
Q4 2022

Feb 07, 2023

SELL
$87.44 - $112.11 $64,355 - $82,512
-736 Reduced 5.17%
13,500 $1.5 Million
Q3 2022

Nov 09, 2022

SELL
$84.53 - $94.96 $45,899 - $51,563
-543 Reduced 3.67%
14,236 $1.23 Million
Q2 2022

Aug 15, 2022

BUY
$83.49 - $94.64 $284,700 - $322,722
3,410 Added 29.99%
14,779 $1.35 Million
Q1 2022

May 09, 2022

BUY
$73.51 - $82.4 $77,553 - $86,932
1,055 Added 10.23%
11,369 $933,000
Q4 2021

Feb 07, 2022

SELL
$72.28 - $90.54 $205,130 - $256,952
-2,838 Reduced 21.58%
10,314 $810,000
Q3 2021

Nov 03, 2021

BUY
$71.68 - $78.83 $69,171 - $76,070
965 Added 7.92%
13,152 $988,000
Q2 2021

Aug 06, 2021

BUY
$70.31 - $77.77 $60,888 - $67,348
866 Added 7.65%
12,187 $948,000
Q1 2021

May 07, 2021

BUY
$68.86 - $81.11 $129,112 - $152,081
1,875 Added 19.85%
11,321 $873,000
Q4 2020

Feb 04, 2021

BUY
$71.77 - $79.65 $70,980 - $78,773
989 Added 11.69%
9,446 $773,000
Q3 2020

Nov 13, 2020

BUY
$73.18 - $82.95 $17,197 - $19,493
235 Added 2.86%
8,457 $702,000
Q2 2020

Aug 10, 2020

BUY
$70.42 - $80.13 $57,462 - $65,386
816 Added 11.02%
8,222 $636,000
Q1 2020

Apr 28, 2020

BUY
$63.36 - $87.82 $105,050 - $145,605
1,658 Added 28.84%
7,406 $622,000
Q4 2019

Jan 27, 2020

SELL
$77.58 - $87.54 $27,773 - $31,339
-358 Reduced 5.86%
5,748 $523,000
Q3 2019

Nov 04, 2019

BUY
$76.08 - $82.93 $100,045 - $109,052
1,315 Added 27.45%
6,106 $519,000
Q1 2019

May 13, 2019

SELL
$69.58 - $79.36 $9,741 - $11,110
-140 Reduced 2.84%
4,791 $398,000
Q4 2018

Jan 31, 2019

SELL
$65.24 - $75.71 $53,692 - $62,309
-823 Reduced 14.3%
4,931 $377,000
Q3 2018

Nov 02, 2018

SELL
$57.69 - $67.84 $11,538 - $13,568
-200 Reduced 3.36%
5,754 $408,000
Q2 2018

Aug 14, 2018

SELL
$50.83 - $59.72 $37,868 - $44,491
-745 Reduced 11.12%
5,954 $361,000
Q1 2018

May 08, 2018

BUY
$50.96 - $59.23 $54,883 - $63,790
1,077 Added 19.16%
6,699 $0
Q4 2017

Feb 12, 2018

BUY
$51.62 - $61.64 $109,073 - $130,245
2,113 Added 60.22%
5,622 $316,000
Q3 2017

Nov 03, 2017

BUY
$58.67 - $63.13 $205,873 - $221,523
3,509
3,509 $225,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $252B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Doliver Advisors, LP Portfolio

Follow Doliver Advisors, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Doliver Advisors, LP, based on Form 13F filings with the SEC.

News

Stay updated on Doliver Advisors, LP with notifications on news.